Concepedia

Publication | Open Access

A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia

DOIFull Paper Access

68

Citations

24

References

2021

Year

Chunrui Li, Wenyue Cao, Yimei Que, Qiuxiang Wang, Yi Xiao, Chaojiang Gu, Di Wang, Jue Wang, Lijun Jiang, Hao Xu,
Clinical and Translational Medicine

Abstract

Anti-BCMA CAR T cell treatment is safe and highly active in R/R multiple myeloma.

References

YearCitations

Page 1